Literature DB >> 17119859

The relationship between nail- and distal phalangeal bone involvement severity in patients with psoriasis.

Gamze Serarslan1, Hayal Güler, Sinem Karazincir.   

Abstract

We aimed to investigate the relationship between nail involvement and joint manifestations and whether there was a correlation between nail psoriasis severity and bone manifestations in psoriatic patients without symptomatic psoriatic arthritis in plaque type psoriasis. Thirty-one patients with nail involvement (16 men, 15 women, mean age 45.29+/-18.73) and 39 patients without nail involvement (16 men, 23 women, mean age 38.41+/-17.33) were enrolled in the study. X-ray of the hands and feet with magnification were performed. The distal interphalangeal (DIP) joint and bone (tuft of terminal phalanx) were evaluated. A scoring method was performed on the patients with nail involvement. There was no difference in DIP joint involvement in patients with or without finger- and toenail involvement (p=0.085 and p=0.062, respectively). However, the prevalence of bone involvement was higher in patients with finger- and toenail involvement than without finger- and toenail involvement (p=0.039 and p=0.021, respectively). A positive correlation was also determined between finger- and toenail psoriasis severity and bone involvement severity (r=0.379, p=0.001 and r=0.288, p=0.015).

Entities:  

Mesh:

Year:  2006        PMID: 17119859     DOI: 10.1007/s10067-006-0476-y

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  8 in total

1.  Asymptomatic erosive peripheral psoriatic arthritis: a frequent finding in Italian patients.

Authors:  C Palazzi; L D'Agostino; E D'Amico; E Pennese; A Petricca
Journal:  Rheumatology (Oxford)       Date:  2003-07       Impact factor: 7.580

2.  Psoriatic arthritis: interrelationships between skin and joint manifestations related to onset, course and distribution.

Authors:  O Elkayam; J Ophir; M Yaron; D Caspi
Journal:  Clin Rheumatol       Date:  2000       Impact factor: 2.980

3.  A classification study of clinical subsets in an inception cohort of early psoriatic peripheral arthritis--'DIP or not DIP revisited'.

Authors:  D Kane; L Stafford; B Bresnihan; O FitzGerald
Journal:  Rheumatology (Oxford)       Date:  2003-07-16       Impact factor: 7.580

4.  Extended report: nail disease in psoriatic arthritis--clinically important, potentially treatable and often overlooked.

Authors:  L Williamson; N Dalbeth; J L Dockerty; B C Gee; R Weatherall; B P Wordsworth
Journal:  Rheumatology (Oxford)       Date:  2004-04-27       Impact factor: 7.580

5.  Psoriatic arthritis (PSA)--an analysis of 220 patients.

Authors:  D D Gladman; R Shuckett; M L Russell; J C Thorne; R K Schachter
Journal:  Q J Med       Date:  1987-02

6.  Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease.

Authors:  S M Jones; J B Armas; M G Cohen; C R Lovell; G Evison; N J McHugh
Journal:  Br J Rheumatol       Date:  1994-09

7.  Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis.

Authors:  Phoebe Rich; Richard K Scher
Journal:  J Am Acad Dermatol       Date:  2003-08       Impact factor: 11.527

8.  Is the involvement of the distal interphalangeal joint in psoriatic patients related to nail psoriasis?

Authors:  Raffaele Scarpa; Francesco Manguso; Alfonso Oriente; Rosario Peluso; Mariangela Atteno; Pasquale Oriente
Journal:  Clin Rheumatol       Date:  2003-12-16       Impact factor: 2.980

  8 in total
  6 in total

1.  Which Psoriasis Patients Develop Psoriatic Arthritis?

Authors:  Kristine Busse; Wilson Liao
Journal:  Psoriasis Forum       Date:  2010

2.  Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study.

Authors:  Floranne C Wilson; Murat Icen; Cynthia S Crowson; Marian T McEvoy; Sherine E Gabriel; Hilal Maradit Kremers
Journal:  Arthritis Rheum       Date:  2009-02-15

3.  Epithelium-Derived Wnt Ligands Are Essential for Maintenance of Underlying Digit Bone.

Authors:  Makoto Takeo; Christopher S Hale; Mayumi Ito
Journal:  J Invest Dermatol       Date:  2016-03-25       Impact factor: 8.551

4.  Infliximab in the treatment of plaque type psoriasis.

Authors:  Rosita Saraceno; Andrea Saggini; Lucia Pietroleonardo; Sergio Chimenti
Journal:  Clin Cosmet Investig Dermatol       Date:  2009-04-03

Review 5.  Infliximab: 12 years of experience.

Authors:  Josef S Smolen; Paul Emery
Journal:  Arthritis Res Ther       Date:  2011-05-25       Impact factor: 5.156

Review 6.  Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease.

Authors:  Rainer Zenz; Robert Eferl; Clemens Scheinecker; Kurt Redlich; Josef Smolen; Helia B Schonthaler; Lukas Kenner; Erwin Tschachler; Erwin F Wagner
Journal:  Arthritis Res Ther       Date:  2008-01-18       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.